Metabolix Company Profile (NASDAQ:MBLX)

Analyst Ratings

Consensus Ratings for Metabolix (NASDAQ:MBLX) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (310.40% upside)

Analysts' Ratings History for Metabolix (NASDAQ:MBLX)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Rodman & RenshawInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2015Jefferies GroupReiterated RatingHold$0.75 -> $0.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Metabolix (NASDAQ:MBLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/13/2016        
5/11/2016Q1($0.23)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/29/2016Q415($0.24)($0.22)$870.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q315($0.26)($0.22)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.26)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2015Q115($0.04)($0.04)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/19/2015Q414($0.09)($0.05)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q3 14($0.16)($0.14)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014($0.23)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014($0.21)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/27/2014($0.21)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q3 13($0.24)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013($0.20)($0.23)$1.57 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.25)($0.20)$1.43 million$1.94 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/26/2013Q4 2012($0.26)($0.28)$1.23 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012($0.24)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.26)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.84$0.84ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012($0.30)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011($0.29)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011($0.33)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011($0.36)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2011($0.37)($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Metabolix (NASDAQ:MBLX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Metabolix (NASDAQ:MBLX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Metabolix (NASDAQ:MBLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/17/2015William P ScullyMajor ShareholderBuy31,833$2.11$67,167.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015William P. Scullymajor shareholderBuy67,500$2.16$145,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015William P ScullyMajor ShareholderBuy25,000$2.71$67,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015William P ScullyMajor ShareholderBuy40,000$2.23$89,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015William P. Scullymajor shareholderBuy42,750$2.15$91,912.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015William P ScullyMajor ShareholderBuy26,600$1.99$52,934.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Birchview Capital Gp, LlcDirectorBuy43,700$3.32$145,084.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Family Foundation SchulerMajor ShareholderBuy1,664,840$3.32$5,527,268.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Joseph H ShaulsonCEOBuy35,000$3.32$116,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Lynne H BrumVPBuy14,570$3.32$48,372.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Walsem Johan VanCOOBuy12,000$3.32$39,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2013Matthew StrobeckDirectorBuy100,000$1.00$100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Richard P EnoCEOBuy20,000$1.17$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2012Nostrand Robert L VanDirectorBuy20,000$1.07$21,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2012Oliver P PeoplesVPBuy40,000$1.07$42,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Metabolix (NASDAQ:MBLX)
DateHeadline
07/26/16 03:09 PMMETABOLIX, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities -
07/21/16 03:06 PM4:06 pm Metabolix announces restructuring under which Yield10 Bioscience will become its core business; will reduce ~half of its workforce; shares halted -
07/21/16 03:05 PMMetabolix Announces New Strategic Direction: Yield10 Bioscience to Become Core Business, Biopolymers Operations to be Wound Down - [GlobeNewswire] - WOBURN, Mass., July 21, 2016-- Metabolix, Inc. announced today that it is implementing a strategic restructuring under which Yield10 Bioscience will become its core business with a focus on developing ...
07/07/16 05:08 PMMetabolix (MBLX) Receives Delisting Notification; Says in Talks with 'Interested Parties'
07/07/16 03:12 PMMETABOLIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T -
06/23/16 12:44 PMETF’s with exposure to Metabolix, Inc. : June 23, 2016 -
06/22/16 11:36 AMMetabolix, Inc. :MBLX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 -
05/30/16 05:52 PMPerformance at a Glance on Metabolix, Inc. (NASDAQ:MBLX) - HNN - Performance at a Glance on Metabolix, Inc. (NASDAQ:MBLX)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Metabolix, Inc. (NASDAQ:MBLX)'s stock has performed at various points in its past. Currently, the ...and more »
05/30/16 05:52 PMStrong Sell Calls Count For Metabolix, Inc. (NASDAQ:MBLX) At 0 - Investor Newswire - Strong Sell Calls Count For Metabolix, Inc. (NASDAQ:MBLX) At 0Investor NewswireMetabolix, Inc. (NASDAQ:MBLX) has a total of 1 Strong Buy calls and 0 Strong Sell advises as of 2016-05-29. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is considered to be ...and more »
05/19/16 03:04 PMMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Se -
05/18/16 08:52 AMMetabolix Raises $2 Million in Amendment to Licensing Deal with Tepha - [at noodls] - May 18, 2016 CAMBRIDGE, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into an amendment to its license agreement with Tepha, Inc., a Lexington, ...
05/16/16 03:52 PMMetabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10 Bioscience Program - [at noodls] - May 16, 2016 CAMBRIDGE, Mass., May 16, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that the Company is exploring strategic alternatives for its specialty biopolymers business ...
04/07/16 08:13 AMMetabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016 - [at noodls] - April 7, 2016 CAMBRIDGE, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced ...
03/30/16 11:56 AMEdited Transcript of MBLX earnings conference call or presentation 29-Mar-16 8:30pm GMT -
03/29/16 03:24 PMMetabolix Announces Fourth Quarter and Full Year 2015 Financial Results - [at noodls] - March 29, 2016 CAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported ...
03/29/16 03:24 PMMetabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement - [at noodls] - March 29, 2016 CAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced ...
03/29/16 03:12 PMMETABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements -
02/26/16 01:26 PMMetabolix : Announces Formation of Scientific Advisory Board for Yield10 Bioscience; Names Danny Schnell, Ph.D. and Michael Lassner, Ph.D, as Members - Release date- 24022016 - CAMBRIDGE, Mass - Metabolix, Inc. (NASDAQ:MBLX), today announced the formation of a Scientific Advisory Board (' SAB ') for Yield10 Bioscience, the crop science venture launched by Metabolix in 2015. The Company also announced that ...
02/24/16 08:00 AMMetabolix Announces Formation of Scientific Advisory Board for Yield10 Bioscience - [GlobeNewswire] - CAMBRIDGE, Mass., Feb. 24, 2016-- Metabolix, Inc., today announced the formation of a Scientific Advisory Board for Yield10 Bioscience, the crop science venture launched by Metabolix in 2015. The Company ...
02/10/16 08:05 AMMetabolix to Provide Company Update at Source Capital Conference - [GlobeNewswire] - CAMBRIDGE, Mass., Feb. 10, 2016-- Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics industry, will review 2015 highlights and discuss its outlook for 2016 ...
02/09/16 06:04 AMCoverage initiated on Metabolix by Rodman & Renshaw -
02/04/16 03:05 PMMetabolix to Present at Source Capital Conference - [GlobeNewswire] - CAMBRIDGE, Mass., Feb. 04, 2016-- Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will review 2015 highlights ...
01/27/16 01:18 PMBiomaterials firm Metabolix to move HQ to Woburn from Cambridge - Metabolix Inc. (Nasdaq: MBLX) has signed a 10.5 year lease agreement for 30,000 square feet of lab and office space at 19 Presidential Way, and expects to move there in June 2016, vacating the Cambridge space, according to a press release from the company ...
01/26/16 03:22 PMMetabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016 - [at noodls] - January 26, 2016 , (GLOBE NEWSWIRE) -- (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has signed a 10.5 year lease agreement ...
01/26/16 03:11 PMMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive -
12/16/15 01:51 PMMetabolix, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/08/15 12:17 PMMETABOLIX, INC. Financials -
11/23/15 03:05 PMMetabolix to Present at the LD Micro Main Event - [GlobeNewswire] - CAMBRIDGE, Mass., Nov. 23, 2015-- Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will make a presentation ...
11/12/15 01:55 PMMETABOLIX, INC. Files SEC form 10-Q, Quarterly Report -
11/10/15 03:30 PMMetabolix Inc Earnings Call scheduled for 4:30 pm ET today -
11/10/15 03:16 PMMetabolix Announces Third Quarter 2015 Financial Results - [at noodls] - Metabolix Announces Third Quarter 2015 Financial Results
11/10/15 03:13 PMMETABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
11/10/15 06:07 AMQ3 2015 Metabolix Inc Earnings Release - After Market Close -
10/30/15 08:15 AMMetabolix to Present at Drexel Hamilton Conference - [GlobeNewswire] - CAMBRIDGE, Mass., Oct. 30, 2015-- Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that management will make a presentation ...
10/27/15 08:37 AMMetabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call - [at noodls] - Metabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call
10/15/15 08:12 AMMetabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration - [at noodls] - Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration
10/07/15 04:18 PMMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securitie -

Social

About Metabolix

Metabolix logoMetabolix, Inc. is an advanced biomaterials company. The Company is engaged in the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants. It is focused on delivering solutions to the plastics industry. It has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company offers three lines of products: biopolymers, bio-based chemicals and crop-based technologies. Its biopolymers include performance additives and functional biodegradation products, such as I6001, I6003rp, Mirel a-PHA copolymer modifier, Mirel Micropowders and Mirel P1003, F1005 for injection molding, among others. The Company's bio-based chemicals include Bio-based GBL/BDO and Bio-based Acrylic Acid. It also develops crop-based technology to co-produce renewable industrial chemicals with bioenergy in integrated bio refineries.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Specialty Chemicals
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MBLX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.73
  • 50 Day Moving Average: $0.790
  • 200 Day Moving Average: $1.280
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $20.27M
  • Beta: 3.24
Additional Links:
Metabolix (NASDAQ:MBLX) Chart for Friday, July, 29, 2016